PT - JOURNAL ARTICLE AU - Wolfe, Marlene K. AU - Duong, Dorothea AU - Hughes, Bridgette AU - Chan-Herur, Vikram AU - White, Bradley J. AU - Boehm, Alexandria B. TI - Detection of monkeypox viral DNA in a routine wastewater monitoring program AID - 10.1101/2022.07.25.22278043 DP - 2022 Jan 01 TA - medRxiv PG - 2022.07.25.22278043 4099 - http://medrxiv.org/content/early/2022/07/26/2022.07.25.22278043.short 4100 - http://medrxiv.org/content/early/2022/07/26/2022.07.25.22278043.full AB - Wastewater represents a composite biological sample from the entire contributing population. People infected with monkeypox excrete monkeypox virus DNA via skin lesions, saliva, feces and urine and these can enter the wastewater via toilets, sinks, and shower drains. To test whether monkeypox can be detected and monitored in wastewater during a period when publicly reported monkey cases in the region were increasing, we deployed digital PCR assays that target genomic DNA from the monkeypox virus in our routine, ongoing wastewater surveillance program in the Greater Bay Area of California, USA. We measured monkeypox virus DNA daily in settled solids samples from nine wastewater plants over the period of approximately 4 weeks. During that period, we detected monkeypox virus DNA in wastewater solids at nearly all the wastewater plants we routinely sample. Frequency of occurrence and concentrations were highest at plants serving San Francisco County. To confirm the presence of monkeypox DNA, we used two assays that target distinct sequences on the monkeypox genome on a subset of samples and results from both assays were in close agreement strongly suggesting true positives in the wastewater. Additionally, we show that concentrations of monkeypox DNA is 103 times higher in the solid fraction compared to the liquid fraction of wastewater on a mass-equivalent basis.Competing Interest StatementDorothea Duong, Bridgette Hughes, Vikram Chan-Herur, and Bradley White are employees of Verily Life Sciences.Funding StatementThis work is supported by a gift from the CDC Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available at wbe.stanford.edu and upon request to the authors. https://wbe.stanford.edu